首页> 外文期刊>The British journal of general practice: the journal of the Royal College of General Practitioners >Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England
【24h】

Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England

机译:对大肠癌风险增加的患者进行粪便免疫化学测试的态度:英国GP的在线调查

获取原文
       

摘要

Background There is increasing interest in using a quantitative faecal immunochemical test (FIT) to rule out colorectal cancer (CRC) in patients with high-risk symptoms in primary care.Aim This study aimed to investigate GPs’ attitudes and willingness to use a FIT over an urgent 2-week wait (2WW) referral.Design and setting A cross-sectional online survey involving 1024 GPs working across England.Method Logistic regression models were used to explore the likelihood of GPs using a FIT instead of a 2WW referral, and reported using odds ratios (ORs) and 95% confidence intervals (95% CIs).Results Just over one-third of GPs ( n = 365) preferred to use a FIT as a rule-out test over a 2WW referral. GPs were more willing if they were: aged 36–45 years (OR 1.59 [95% CI = 1.04 to 2.44]); 46–55 years (OR 1.99 [95% CI = 1.14 to 3.47]); thought a FIT was highly accurate (OR 1.63 [95% CI = 1.16 to 2.29]); thought patients would benefit compared with having a colonoscopy (OR 2.02 [95% CI = 1.46 to 2.79]); and were highly confident about discussing the benefits of a FIT (OR 2.14 [95% CI = 1.46 to 3.16]). GPs were less willing if they had had 10 urgent referrals in the past year (OR 0.62 [95% CI = 0.40 to 0.94]) and thought that longer consultations would be needed (OR 0.61 [95% CI = 0.44 to 0.83]).Conclusion The study findings suggest that the acceptability of using a FIT as a rule-out test in primary care is currently low, with less than half of GPs who perceived the test to be accurate preferring it over colonoscopy. Any potential guideline changes recommending a FIT in patients with high-risk symptoms, instead of urgent referral to rule out CRC, are likely to require intensive supporting educational outreach to increase GP confidence in the accuracy and application of a FIT in this context.
机译:背景技术在初级保健中具有高风险症状的患者中,使用定量粪便免疫化学测试(FIT)排除大肠癌(CRC)的兴趣日益浓厚。目的本研究旨在调查全科医生对FIT用于大肠癌的态度和意愿。紧急的2周等待(2WW)推荐。设计和设置涉及1024个全英工作的横断面在线调查。方法采用Logistic回归模型探索使用FIT而不是2WW推荐的GP的可能性,并报告结果使用略微比率(OR)和95%置信区间(95%CI)。结果超过三分之一的GP(n = 365)首选使用FIT作为2WW转诊的排除测试。 GP愿意的话:36-45岁(OR 1.59 [95%CI = 1.04至2.44]); 46-55年(OR 1.99 [95%CI = 1.14至3.47]);认为FIT非常准确(OR为1.63 [95%CI = 1.16至2.29]);认为与结肠镜检查相比患者会受益(OR 2.02 [95%CI = 1.46至2.79]);并对讨论FIT的好处充满信心(OR为2.14 [95%CI = 1.46至3.16])。如果他们在过去一年中有10次以上的紧急转诊,GP则不太愿意(OR 0.62 [95%CI = 0.40至0.94]),并认为需要更长的咨询时间(OR 0.61 [95%CI = 0.44至0.83])结论研究结果表明,目前在初级保健中使用FIT作为排除检查的接受度较低,只有不到一半的全科医生认为该检查比结肠镜检查更准确。建议对有高风险症状的患者进行FIT的任何潜在指南更改,而不是紧急转诊以排除CRC的可能,都可能需要加强支持的教育推广,以提高GP对FIT在这种情况下的准确性和应用的信心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号